Pulse
Prudentia Sciences, Inc · Operations & Productivity
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
Prudentia Pulse provides emerging biotech companies with a rapid yet highly-scientific and technical assessment of their asset. Through Prudentia's proprietary framework, we generate a comprehensive asset assessment across all scientific domains (eg. CMC, Discovery, Pre-Clinical, Clinical, Commercial, IP, and Regulatory) to give customers the confidence they need going into potential investor or partnership discussions.
Highlights
Highlighted by the publisher on AWS Marketplace.
- Seamless & secure dataroom connectivity - Access to \"Rest of World\" public data sources to fill data gaps - Identify key risks and potential areas of concern prior to meeting with investors - Stage your asset to maximize your probability of success - Understand potential asset eNPV and key drivers that impact value
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Plans and pricing as listed
1 listed- Units
Refund terms
As stated by the publisher on AWS Marketplace.
Contact our support team for refund information.
Sources
Linked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.

